Identification of the von Hippel-Lindau (VHL) gene. Its role in renal cancer - PubMed (original) (raw)
Review
. 1995 Feb 15;273(7):564-70.
Affiliations
- PMID: 7837390
Review
Identification of the von Hippel-Lindau (VHL) gene. Its role in renal cancer
W M Linehan et al. JAMA. 1995.
No abstract available
Similar articles
- Molecular genetic studies of sporadic and familial renal cell carcinoma.
Gnarra JR, Glenn GM, Latif F, Anglard P, Lerman MI, Zbar B, Linehan WM. Gnarra JR, et al. Urol Clin North Am. 1993 May;20(2):207-16. Urol Clin North Am. 1993. PMID: 8098558 Review. - Mutational analysis of endothelial cells derived from von Hippel-Lindau-related renal cancer.
Los M, Kerckhaert OA, Zewald R, van Amstel HK, Voest EE. Los M, et al. J Natl Cancer Inst. 2000 Oct 18;92(20):1688-9. doi: 10.1093/jnci/92.20.1688. J Natl Cancer Inst. 2000. PMID: 11036115 No abstract available. - Detection of a germline mutation and somatic homozygous loss of the von Hippel-Lindau tumor-suppressor gene in a family with a de novo mutation. A combined genetic study, including cytogenetics, PCR/SSCP, FISH, and CGH.
Decker HJ, Neuhaus C, Jauch A, Speicher M, Ried T, Bujard M, Brauch H, Störkel S, Stöckle M, Seliger B, Huber C. Decker HJ, et al. Hum Genet. 1996 Jun;97(6):770-6. doi: 10.1007/BF02346188. Hum Genet. 1996. PMID: 8641695 - Germ-line mutations in the von Hippel-Lindau tumor-suppressor gene are similar to somatic von Hippel-Lindau aberrations in sporadic renal cell carcinoma.
Whaley JM, Naglich J, Gelbert L, Hsia YE, Lamiell JM, Green JS, Collins D, Neumann HP, Laidlaw J, Li FP, et al. Whaley JM, et al. Am J Hum Genet. 1994 Dec;55(6):1092-102. Am J Hum Genet. 1994. PMID: 7977367 Free PMC article. - Renal cell carcinoma. Molecular genetics and clinical implications.
Jennings SB, Gnarra JR, Walther MM, Zbar B, Linehan WM. Jennings SB, et al. Surg Oncol Clin N Am. 1995 Apr;4(2):219-29. Surg Oncol Clin N Am. 1995. PMID: 7796282 Review.
Cited by
- von Hippel-Lindau disease-associated hemangioblastomas are derived from embryologic multipotent cells.
Park DM, Zhuang Z, Chen L, Szerlip N, Maric I, Li J, Sohn T, Kim SH, Lubensky IA, Vortmeyer AO, Rodgers GP, Oldfield EH, Lonser RR. Park DM, et al. PLoS Med. 2007 Feb;4(2):e60. doi: 10.1371/journal.pmed.0040060. PLoS Med. 2007. PMID: 17298169 Free PMC article. - Update on the management of familial central nervous system tumor syndromes.
Hottinger AF, Khakoo Y. Hottinger AF, et al. Curr Neurol Neurosci Rep. 2007 May;7(3):200-7. doi: 10.1007/s11910-007-0031-5. Curr Neurol Neurosci Rep. 2007. PMID: 17488585 Review. - Elongin BC complex prevents degradation of von Hippel-Lindau tumor suppressor gene products.
Schoenfeld AR, Davidowitz EJ, Burk RD. Schoenfeld AR, et al. Proc Natl Acad Sci U S A. 2000 Jul 18;97(15):8507-12. doi: 10.1073/pnas.97.15.8507. Proc Natl Acad Sci U S A. 2000. PMID: 10900011 Free PMC article. - A novel pancreatic endocrine tumor suppressor gene locus on chromosome 3p with clinical prognostic implications.
Chung DC, Smith AP, Louis DN, Graeme-Cook F, Warshaw AL, Arnold A. Chung DC, et al. J Clin Invest. 1997 Jul 15;100(2):404-10. doi: 10.1172/JCI119547. J Clin Invest. 1997. PMID: 9218518 Free PMC article. - Whole-exome sequencing and immunohistochemistry findings in von Hippel-Lindau disease.
Guo X, Gao L, Hong X, Guo D, Di W, Wang X, Xu Z, Xing B. Guo X, et al. Mol Genet Genomic Med. 2019 Sep;7(9):e880. doi: 10.1002/mgg3.880. Epub 2019 Jul 17. Mol Genet Genomic Med. 2019. PMID: 31317677 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical